BBlogFlow

Health watchdog group warns of private clinic fees and alleges underutilization of hospital MRIs - CTV News

·Sep 16, 2026

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. CTV News

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Direct spending on Canadian military could reach more than $163B by 2035: budget watchdog - CBC

PoliticsDirect spending on the Canadian military could reach $163.6 billion by 2035 under the Liberal government's proposal to meet NATO's benchmark target of five per cent of GDP, the Parliamentary Budget Office in a new report on Tuesday. Parliamentary Budget Office report says many unknowns remain, which could affect government financesMurray Brewster · CBC News · Posted: Oct 06, 2026 11:54 AM EDT | Last Updated: October 6Listen to this articleEstimated 3 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. A scale model of a ThyssenKrupp Marine Systems HDW Class 212CD submarine is shown at the Canadian Association of Defence and Security Industries annual trade show, CANSEC, in Ottawa on May 27. (Justin Tang/The Canadian Press)Direct spending on the Canadian military could reach $163.6 billion by 2035 under the Liberal government's proposal to meet NATO's benchmark target of five per cent of GDP, the Parliamentary Budget Office said Tuesday.

CBC·

Bioengineer.org | Switching HIV drugs or adding zoledronic acid rebuilds bone lost to tenofovir - European AIDS Treatment Group

Bioengineer.org news storyFor millions of people living with HIV, antiretroviral therapy has transformed a once-fatal infection into a manageable chronic condition. Yet the very drugs that suppress the virus can carry quiet costs, and one of the most insidious is bone loss. Tenofovir disoproxil fumarate, or TDF, has been a cornerstone of HIV treatment worldwide for two decades, prized for its potency, durability, and low cost. But a growing body of evidence has linked TDF exposure to measurable reductions in bone mineral density, raising an increasingly urgent clinical question: once bone has been lost on a TDF-based regimen, can it be recovered? A new prospective cohort study, published in BMC Infectious Diseases, offers some of the most detailed longitudinal evidence to date that the answer, for many patients, is yes. The research team enrolled 223 virologically suppressed men living with HIV who had low bone mineral density while taking TDF-based antiretroviral therapy.

European AIDS Treatment Group·